entropy and solvation energy; 4) acceptance or rejection of the total energy based on the Metropolis criterion and return to step (1). The binding between the small molecules and JAK2 were evaluated with a full-atom ICM ligand binding score 11 from a multireceptor screening benchmark as a compromise between approximated Gibbs free energy of binding and numerical errors. The score was calculated by:
S bind = E int + TΔS Tor + E vw + α 1 E el + α 2 E hb + α 3 E hp + α 4 E sf where E vw , E el , E hb , E hp , and E sf are van der Waals, electrostatic, hydrogen bonding, and nonpolar and polar atom solvation energy differences between bound and unbound states, respectively. E int is the ligand internal strain, ΔS Tor is its conformational entropy loss upon binding, and T = 300 K, and α i are ligand-and receptor independent constants. High-throughput molecular docking. We performed in silico screening on natural product and natural product-like databases on the DOLPHIN kinase model using the internal coordinate mechanics (ICM) method [ICM-Pro 3.6-1d molecular docking software (Molsoft) to identify natural product scaffolds as Type II JAK2 inhibitors. Three natural product databases were used in our virtual screening campaign: the Analyticon Discovery NATx and MEGabolite databases (20,000 compounds, Germany), the ZINC natural product database (90,000 compounds, USA) and the Hongcam natural products database (160,000 compounds, China). Due to the overlap of the three databases, the total number of unique compounds screened was about 150,000. Molecular docking was performed using the virtual library screening (VLS) module in the ICM-Pro 3.6-1d program (Molsoft). Each compound in the library was assigned the MMFF3 force field atom types and charges and was then subjected to Cartesian minimization. During the docking analysis, the ligand was considered flexible and the binding pose and internal torsions were sampled by the BPMC minimization procedure, which involved local energy minimization after each random move. Each compound was docked to the protein binding pocket, and a score from the docking was assigned to each compound according to the weighed component of the ICM scoring function described above. Each compound was docked three times to ensure the convergence of the Monte Carlo optimization, and the minimum score of each ligand from the three independent docking experiments was retained and used for ranking.
ELISA
Recombinant JAK2 (15 μM) was incubated with the indicated concentrations of compound or DMSO for 5 min at room temperature in reaction buffer (60 mM HEPES pH 7.5, 5 mM MgCl 2 , 5 mM MnCl 2 , 3 μM Na 3 VO 4 , 1.25 mM DTT). The reaction was initiated by the addition of indicated concentrations of ATP and biotinylated peptide substrate (1.5 μM), and the mixture was incubated at room temperature for 30 min. The reaction was stopped by the addition of EDTA (50 mM, pH 8), transferred to a 96-well streptavidin coated plate and incubated at room temperature for 60 min. The wells washed with three times with PBS/0.05% Tween 20 (PBST) and incubated with anti-phospho-tyrosine mouse monoclonal antibody at room temperature for 60 min. The wells were washed as before and incubated with horseradish peroxide-conjugated anti-mouse secondary antibody at room temperature for 30 min. The wells were washed five times with PBST, incubated with 100 μL TMB solution, quenched with 100 μL 2N sulfuric acid, and the absorbance was measured at  = 450 nm. Three independent experiments were performed.
Cytotoxicity test (MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-tetrazolium bromide) assay) HEL cells were seeded in a 96-well flat-bottomed microplate at 8000 cells/well in 100 μL of Dulbecco's modified Eagle's medium (DMEM, Gibco) containing 10% fetal bovine serum (Invitrogen) and 1% antibiotic and antimycotic solution (Sigma). The compounds were dissolved in DMSO and mixed with the growth medium (final DMSO concentration ≤ 4%) respectively. Serial dilution of each complex were added to each well. The microplate was incubated at 37 °C, 5% CO 2 , 95% air in a humidified incubator for 72 h. After incubation, 10 μL MTT reagent (5 mg/mL) was added to each well. The microplate was re-incubated at 37 °C in 5% O 2 for 4 h. DMSO (100 μL) was added to each well. The microplate was further incubated for 15 min. The absorbance at 570 nm was measured using a microplate reader. The IC 50 values of the compounds (concentration required to reduce the absorbance by 50% compared to the control) were determined by the dose-dependence of surviving cells. This assay was repeated three times independently.
Antiviral assay
The firefly (FF)-luciferase reporter activity was used to monitor the replication of HCV replicons in Huh-luc/neo-ET cells as previously described. 12 Replicon cells were seeded at a density of 5  10 3 cells per well in 96-well plates and were incubated in duplicate with dimethyl sulfoxide (DMSO) or serially diluted NVP-BBT594, or amentoflavone analogues (1a, 1b, 1c and 1g) at 37 °C for 72 h. Cells were lysed with ice-cold passive lysis reagent and the luciferase activity was measured with a luciferase assay kit (Promega) and a Tecan FARCyte luminometer (GE Healthcare) according to the manufacturers' instructions. The numbers of relative light units (RLU) were determined as percentage readings relative to the level for the compound-free controls. The EC 50 was determined by nonlinear regression analysis using Origin 6.1 (OriginLab Software). Two independent experiments were conducted for this assay.
Western blot analysis
1  10 6 HEL cells were treated with the indicated concentrations of compound or DMSO for 16 h. Cells were washed three times with cold PBS, resuspended in RIPA lysis buffer, and incubated on ice for 30 min. Cell debris was removed by centrifugation at 14,000 rpm for 30 min at 4 °C, and the protein concentration of the supernatant was determined with Bio-Rad protein assay dye reagent (Bio-Rad). Equal protein amounts were electrophoresed on a 10% SDS-PAGE and transferred to a PVDF membrane. The membrane was blocked with 5% milk for 1 h, and probed with anti-phospho-JAK2 Y1007/Y1008 rabbit antibody or antiphospho-STAT3 (Y705) rabbit antibody in 5% milk overnight at 4 °C. The membrane was washed with PBST and incubated with horseradish peroxide-conjugated anti-rabbit secondary antibody in 5% milk for 1 h at room temperature. Protein bands were detected using enhanced chemiluminescence as specified by the manufacturer (ECL, Thermo). Membranes were stripped and reprobed with anti-JAK2 goat antibody or anti-STAT3 antibody to confirm equal protein loading. Three independent experiments were performed.
Preparative: Reactions were monitored by thin layer chromatography (TLC) using E. Merck silica gel plates, Kieselgel 60 F 254 with 0.2 mm thickness. Components were visualized by illumination with short-wavelength ultra-violet light and/or staining. Flash column chromatography was performed with E. Merck silica gel 60 (230-400 mesh ASTM).
Amentoflavone was purchased from the Shenzhen ChemStrong Scientific Co. Ltd. n-Heptanoyl chloride was purchased from Acros Organics. Solvents and commercially available reagents were used as received.
In the synthetic strategy, amentoflavone 1a was treated with an excess of heptanoyl chloride in pyridine at 60 °C overnight to afford the peracyled derivative 2a (Scheme S1). Warming the reaction of 2a and the appropriate alkyl bromides in the presence of potassium carbonate promoted selective hydrolysis and alkylation at the C7 and C7″ phenolic positions, to generate mixtures of three products: the 7-monoalkylated derivatives 3a, 7″-monoalkylated derivatives 3b and the 7,7″-dialkylated derivatives 3c. The reaction of 2a with farnesyl bromide proceeded under milder conditions. Because 3a-c were very similar in polarity, the mixtures, without further purification, were directly hydrolyzed under acidic conditions using 3M HCl/MeOH. For the synthesis of 1j, deprotection was induced under basic conditions. The deacylated derivatives 1b-j were isolated and purified by repeated preparative TLC or HPLC.
Analytical: 1 H and 13 C NMR nuclear magnetic resonance spectra were recorded in deuterochloroform (CDCl 3 ) or deuteroacetone (acetone-d 6 ), with tetramethylsilane (TMS) as an internal standard at ambient temperature on a Bruker Avance 400 spectrometer operating at 400 MHz for 1 H, and at 100 MHz for 13 C. All spectra were calibrated at  7.26 or  0.00 ppm for 1 H spectra (residual CHCl 3 or TMS respectively), and 77.16 ppm for 13 C spectra. Splitting patterns are designated as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. Maldi-TOF-HRMS analysis was performed using a Bruker Autoflex II mass spectrometer (Bruker Daltonics, Germany), with accurate mass reported for the molecular ion (M + ) or next largest fragment thereof. Preparative HPLC was carried out on a Waters HPLC with a 510 HPLC pump and 410 differential refractometer. General procedure for the synthesis of 3a-c . Peracylated amentoflavone (2a, 121 mg, 0.100 mmol) and the corresponding alkyl bromide (0.50 mmol) were dissolved in acetone (2.0 mL), and K 2 CO 3 (138 mg, 1.00 mmol) was added in one portion. The mixture was stirred at 55 °C for 12 h and filtered through a pad of silica gel. The volatiles were evaporated in vacuo to give a mixture of three alkylation products (3a-c), which were used in the next step without further purification. 183.7, 183.1, 165.4, 165.1, 165.0, 163.7, 163.5, 162.0, 160.1, 158.9, 155.4, 132. 
